Patho-Seq
Patho-Seq is a new combination of sequencing protocol and Ripseq technologies adapted to meet FDA’s
specific requirements for approval for clinical use. Patho-Seq WILL NOT be available for sale until it has
received FDA marketing approval. If you wish to use Pathogenomix’s current technologies for research-only
purposes, please see the RipSeq tab.